Xylem Inc (NYSE:XYL) Stock Holdings Decreased by Davidson Investment Advisors

Davidson Investment Advisors lowered its stake in Xylem Inc (NYSE:XYL) by 0.4% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 67,476 shares of the industrial products company’s stock after selling 265 shares during the period. Davidson Investment Advisors’ holdings in Xylem were worth $5,372,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in XYL. City Holding Co. boosted its holdings in shares of Xylem by 116.7% in the 3rd quarter. City Holding Co. now owns 325 shares of the industrial products company’s stock valued at $26,000 after buying an additional 175 shares during the period. FinTrust Capital Advisors LLC boosted its holdings in shares of Xylem by 1,530.4% in the 2nd quarter. FinTrust Capital Advisors LLC now owns 375 shares of the industrial products company’s stock valued at $31,000 after buying an additional 352 shares during the period. Winthrop Partners WNY LLC acquired a new position in shares of Xylem in the 3rd quarter valued at about $32,000. Private Ocean LLC acquired a new position in shares of Xylem in the 2nd quarter valued at about $33,000. Finally, Valeo Financial Advisors LLC boosted its stake in Xylem by 500.0% during the 3rd quarter. Valeo Financial Advisors LLC now owns 420 shares of the industrial products company’s stock valued at $33,000 after purchasing an additional 350 shares during the period. 84.94% of the stock is owned by institutional investors.

XYL has been the subject of a number of analyst reports. Cfra lowered shares of Xylem from a “buy” rating to a “hold” rating in a research note on Friday, November 1st. Jefferies Financial Group initiated coverage on shares of Xylem in a research note on Friday, September 20th. They set a “buy” rating and a $90.00 target price for the company. Seaport Global Securities lowered shares of Xylem from a “buy” rating to a “neutral” rating in a research note on Monday, November 4th. Zacks Investment Research lowered shares of Xylem from a “hold” rating to a “sell” rating and set a $82.00 target price for the company. in a research note on Monday, October 14th. Finally, Credit Suisse Group set a $78.00 target price on shares of Xylem and gave the company a “hold” rating in a research note on Friday, November 1st. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and seven have issued a buy rating to the company. The company presently has an average rating of “Hold” and an average target price of $82.30.

In other news, SVP Colin R. Sabol sold 4,099 shares of the company’s stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $78.37, for a total value of $321,238.63. Following the completion of the sale, the senior vice president now directly owns 33,518 shares of the company’s stock, valued at approximately $2,626,805.66. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, SVP Kenneth Napolitano sold 5,000 shares of the company’s stock in a transaction that occurred on Monday, October 7th. The stock was sold at an average price of $75.90, for a total transaction of $379,500.00. Following the completion of the sale, the senior vice president now directly owns 36,228 shares of the company’s stock, valued at $2,749,705.20. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 16,959 shares of company stock valued at $1,313,986. Company insiders own 0.85% of the company’s stock.

Xylem stock traded up $0.28 during midday trading on Tuesday, reaching $76.09. 49,459 shares of the stock traded hands, compared to its average volume of 1,008,098. The company has a current ratio of 1.55, a quick ratio of 1.15 and a debt-to-equity ratio of 0.70. The firm has a fifty day moving average price of $78.68 and a two-hundred day moving average price of $78.82. The firm has a market cap of $13.93 billion, a price-to-earnings ratio of 26.42, a PEG ratio of 1.55 and a beta of 1.18. Xylem Inc has a fifty-two week low of $60.65 and a fifty-two week high of $85.67.

Xylem (NYSE:XYL) last issued its quarterly earnings results on Thursday, October 31st. The industrial products company reported $0.82 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.82. The company had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.33 billion. Xylem had a net margin of 9.65% and a return on equity of 19.14%. The business’s revenue for the quarter was up .7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.77 EPS. Analysts anticipate that Xylem Inc will post 3.02 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 5th. Stockholders of record on Thursday, October 31st will be paid a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a dividend yield of 1.26%. The ex-dividend date is Wednesday, October 30th. Xylem’s dividend payout ratio is currently 33.33%.

Xylem Profile

Xylem Inc engages in the design, manufacture, and servicing of engineered products and solutions for the water and wastewater applications. It operates in three segments: Water Infrastructure, Applied Water, and Measurement & Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation and treatment of water.

Featured Story: What are the benefits of a balanced fund?

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.